The Swedish Patent and Market Court rejected Apotekstjänst Sverige AB’s appeal regarding the sale of Svensk dos AB

Oriola Corporation  Investor news  20 November 2024 at 10:00 a.m. EET

The Swedish Patent and Market Court rejected Apotekstjänst Sverige AB’s appeal regarding the sale of Svensk dos AB

The Swedish Patent and Market Court has rejected Apotekstjänst Sverige AB’s appeal regarding the sale of Svensk dos AB. Consequently, the Swedish Competition Authority’s decision from April 2024, which prohibits Oriola from selling Svensk dos AB to Apotekstjänst Sverige AB, remains in effect.

Apotekstjänst Sverige AB may appeal this decision to the Patent and Market Court of Appeal (patent- och marknadsöverdomstolen). Oriola remains committed to exiting the dose dispensing business in Sweden, but the decision to pursue further appeals rests with Apotekstjänst Sverige AB.

On 13 October 2023, Oriola announced the sale of all shares in Svensk dos AB to Apotekstjänst Sverige AB. Since then, Oriola has not seen a foreseeable recovery of the business due to the current tender market structure and dynamics. Therefore, Oriola’s position remains unchanged.

Oriola Corporation

Further information:

Petter Sandström
General Counsel
tel. +358 10 429 5761
e-mail: petter.sandstrom@oriola.com

Distribution:

Nasdaq Helsinki Ltd.
Key media